Omnicare receives court approval for sale to GenieRx Holdings following bankruptcy proceedings

US long-term care pharmacy provider Omnicare has secured court approval for the sale of its business to GenieRx Holdings LLC, a joint venture between private investment firm Milrose Capital and healthcare investment and management company Integro Healthcare Services, following a comprehensive sale process conducted under Chapter 11 bankruptcy proceedings.

According to CVS Health, the US Bankruptcy Court for the Northern District of Texas approved the transaction, paving the way for Omnicare to transition out of CVS Health's ownership and into private hands. The deal is expected to close later in 2026, subject to regulatory approval and customary closing conditions.

Omnicare President David Azzolina said the court approval provides clarity for the business and its customers. "Today's approval marks an important milestone. We are entering this next phase with clarity on what matters most: delivering reliable pharmacy services, maintaining safe and clinically appropriate care, and being transparent and fair in how we operate."

Rowan Farber, CEO of Integro Healthcare Services, said the acquisition reflects confidence in Omnicare's established position in the long-term care sector. "We admire the trust Omnicare has earned with its customers over decades of serving skilled nursing and assisted living partners, and we look forward to working collaboratively with their team to continue building on that strong foundation and legacy."

Omnicare provides pharmacy services to residents in skilled nursing and assisted living facilities across the United States. Until the transaction closes, the company said its operational priorities remain unchanged, with continued focus on compliance, billing management, delivery reliability and support for residents with higher acuity care needs.

GenieRx's investment signals renewed private sector confidence in the long-term care pharmacy market, a segment under sustained pressure from rising acuity levels, complex medication management requirements across the US healthcare system.

Read the full coverage on the Omnicare sale approval.